(Q24298373)

Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus

GOA release 2020-03-11

1 reference

1 reference

1

0 references

Rongtuan Lin

series ordinal

3

object named as

Rongtuan Lin

0 references

author name string

Judith Lacoste

series ordinal

2

0 references

language of work or name

English

0 references

publication date

30 November 2006

0 references

published in

Biochemical Pharmacology

0 references

volume

72

0 references

issue

11

0 references

page(s)

1477-84

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Expression of hepatitis C virus core protein inhibits interferon-induced nuclear import of STATs

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Recent advances in the molecular biology of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Cell type-specific involvement of RIG-I in antiviral response

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

VISA is an adapter protein required for virus-triggered IFN-beta signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Multiple signaling pathways leading to the activation of interferon regulatory factor 3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Involvement of the IRF family transcription factor IRF-3 in virus-induced activation of the IFN-beta gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

NAK is an IkappaB kinase-activating kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Unscrambling hepatitis C virus-host interactions

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Evasion of intracellular host defence by hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Toll-like receptor signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Immunology of hepatitis B virus and hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Epidemiology of hepatitis C: geographic differences and temporal trends

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Robust hepatitis C virus infection in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Regulation of PKR and IRF-1 during hepatitis C virus RNA replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Whence interferon? Variety in the production of interferon in response to viral infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Differential requirement for TANK-binding kinase-1 in type I interferon responses to toll-like receptor activation and viral infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Suppression of interferon-induced antiviral activity in cells expressing hepatitis C virus proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Effects of the hepatitis C virus core protein on innate cellular defense pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300.

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Structure and function of the interferon-beta enhanceosome

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Triggering the interferon antiviral response through an IKK-related pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Complete replication of hepatitis C virus in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Efficient Replication of Hepatitis C Virus Genotype 1a RNAs in Cell Culture

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Membrane association of the RNA-dependent RNA polymerase is essential for hepatitis C virus RNA replication

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Stealth and cunning: hepatitis B and hepatitis C viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

IRF family of transcription factors as regulators of host defense

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Combination therapy with interferon and ribavirin in the treatment of chronic hepatitis C infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

The therapeutic potential of NS3 protease inhibitors in HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021

Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.BCP.2006.06.030

7 January 2021